Plexus (PLXS) Up 1.4% Since Last Earnings Report: Can It Continue?
Plexus (PLXS) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Zacks
More News
If You Invested $100 In Plexus Stock 20 Years Ago, You Would Have This Much Today
Plexus (NASDAQ:PLXS) has outperformed the market over the past 20 years by 3.98% on an annualized basis producing an average annual return of 13.24%. Currently, Plexus has a market capitalization of $6.54 billion.read more...
Benzinga
Can Plexus (PLXS) Climb 25.22% to Reach the Level Wall Street Analysts Expect?
The average of price targets set by Wall Street analysts indicates a potential upside of 25.2% in Plexus (PLXS). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock.
Zacks
Zacks.com featured highlights Plexus, Twilio and MACOM
Plexus, Twilio and MACOM have been highlighted in this Screen of The Week article.
Zacks
Earnings Estimates Rising for Plexus (PLXS): Will It Gain?
Plexus (PLXS) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.
Zacks
Plexus (PLXS) Is Up 7.56% in One Week: What You Should Know
Does Plexus (PLXS) have what it takes to be a top stock pick for momentum investors? Let's find out.
Zacks
These 4 Electronics-Manufacturing Stocks Are Surging, and It's Still Time to Buy
Electronics manufacturing services (EMS) providers are benefiting from a powerful combination of secular technology investment, rising product complexity, and increased outsourcing by original equipment manufacturers (OEMs).
Zacks
Plexus Q3 Beat, Strong Outlook Clouded by Free Cash Flow Concerns
PLXS' broad Q3 beat and stronger growth outlook extend its runway, but rising working-capital needs put free cash flow conversion under scrutiny.
Zacks
Should Investors Buy PLXS as Growth Accelerates but Cash Flow Weakens?
Plexus is delivering faster growth, higher earnings and wider margins, but premium valuation and weaker near-term cash flow temper the buy case.
PLXS beats fiscal Q3 estimates as revenues jump 28%, fueled by Industrial strength, program ramps and broad demand, while its outlook signals more growth.